Drug class in one race
Synaptic vesicle glycoprotein 2A (SV2A) drugs for Epilepsy
2 tracked Synaptic vesicle glycoprotein 2A (SV2A) drugs in the Epilepsy race. The class explanation lives on the Synaptic vesicle glycoprotein 2A (SV2A) page; the full indication pipeline across every mechanism is on the Epilepsy page.
2 approved / phase 4
Head-to-head evidence: Brivaracetam vs Levetiracetam (Elepsia XR)